Find clinical trials in your area

Search by disease and location to discover available clinical trials matching your criteria.

Matched clinical trials

  • Study Comparing Pembrolizumab and Chemotherapy for Patients with Advanced or Recurrent Endometrial Cancer

    Not recruiting

    1 1 1 1
    Belgium Czechia Denmark Finland Germany Hungary +7
  • Study of Pembrolizumab and Axitinib Combination Versus Sunitinib for Patients with Advanced or Metastatic Kidney Cancer

    Not recruiting

    1 1 1 1
    Investigated diseases:
    Czechia France Germany Hungary Ireland Poland +1
  • Study of NMS-03592088 for Patients with Relapsed or Refractory Acute Myeloid Leukemia (AML) or Chronic Myelomonocytic Leukemia (CMML)

    Not recruiting

    1 1
    Investigated diseases:
    Investigated drugs:
    France Italy Spain
  • Study of Pembrolizumab, Trastuzumab, and Chemotherapy for Patients with HER2 Positive Advanced Stomach or Gastroesophageal Junction Cancer

    Not recruiting

    1 1 1
    France Germany Ireland Italy Poland Spain
  • Study Comparing Enfortumab Vedotin and Pembrolizumab with Chemotherapy for Patients with Muscle-Invasive Bladder Cancer

    Not recruiting

    1 1 1 1
    Bulgaria Croatia Czechia France Germany Greece +6
  • Study of Adagrasib Dosing in Patients with Previously Treated Non-Small Cell Lung Cancer with KRAS G12C Mutation

    Not recruiting

    1 1
    Investigated diseases:
    Investigated drugs:
    Croatia France Greece Hungary Italy The Netherlands +3
  • Study on the Effectiveness and Safety of Ocrelizumab, Methylprednisolone, and Diphenhydramine Hydrochloride in Patients with Multiple Sclerosis

    Not recruiting

    1 1 1 1
    Belgium Bulgaria Croatia Denmark France Hungary +8
  • Study on the Effectiveness and Safety of SAR441566 for Adults with Moderate to Severe Plaque Psoriasis

    Not recruiting

    Investigated diseases:
    Investigated drugs:
    Bulgaria Czechia Germany Hungary Poland Portugal +1
  • Study on the Safety and Tolerability of TransCon IL-2 β/γ, Pembrolizumab, and Chemotherapy in Adults with Advanced or Metastatic Solid Tumors

    Not recruiting

    1 1 1
    Investigated diseases:
    Belgium Italy Poland Spain
  • Study on Brentuximab Vedotin and Drug Combination for Patients with Peripheral T-cell Lymphoma with Less Than 10% CD30 Expression

    Not recruiting

    1 1 1
    France Italy Spain